Alcon (ALC) EBIT Margin (2009 - 2026)

Alcon (ALC) posted quarterly EBIT Margin of 98.77% for Q1 2026, down 0.79% quarter-over-quarter from 99.56% in Q4 2025.

Alcon (ALC) EBIT Margin (2009 - 2026) Analysis & Trends

Alcon's EBIT Margin history runs 11 years deep, the most recent figure standing at 98.77% for Q1 2026.

In Q1 2026, EBIT Margin changed N/A year-over-year to 98.77%; the TTM figure through Mar 2026 stood at 77.34% (changed N/A YoY), while the FY2025 annual figure was 13.18%, down 119.0% from the prior year.
EBIT Margin for Q1 2026 stood at 98.77%, down from 99.56% in the prior quarter.
The five-year high for EBIT Margin was 99.56% in Q4 2025, with the low at 16.51% in Q4 2024.
The 5-year median for EBIT Margin is 23.77% (2023), against an average of 33.69%.
The sharpest annual moves came in 2022 and 2025: EBIT Margin sank 8842 bps in 2022, then soared 11607 bps in 2025.
Alcon's EBIT Margin stood at 20.46% in 2022, then gained by 11 bps to 22.81% in 2023, then plunged by 172 bps to 16.51% in 2024, then jumped by 703 bps to 99.56% in 2025, then declined by 1 bps to 98.77% in 2026.
Business Quant data shows ALC's EBIT Margin at 98.77% in Q1 2026, 99.56% in Q4 2025, and 99.38% in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EBIT Margin (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn	33.60%
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn	13.31%
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn	0.39%
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn	30.66%
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn	5.14%
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn	20.53%
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn	8.19%
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn	-2.87%
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn	7.33%
10	Align Technology	11.37 Bn	10.27 Bn	757.43 Mn	14.58%

Download Data